Scientists have solved a key parasitic puzzle, revealing the unique and complex structures toxoplasmosis and malaria parasites make in order to survive in different hosts.
Following the success of the first Global Image of the Year Life Science Light Microscopy Award, Olympus has launched its second annual Global Image of the Year Award to recognise the best in life science imaging.
Bruker Corporation and Evosep have announced major progress in high-sensitivity, quantitative true single-cell proteomics, using a modified timsTOF Pro mass spectrometer connected to an Evosep One low-flow chromatography system.
A new textbook entitled Evolutionary Diversity as a Source for Anticancer Molecules discusses evolutionary diversity as a source for anticancer agents derived from bacteria, algae, bryophytes, pteridophytes, and gymnosperms.
The past year has proved challenging for readers, contributors and commercial colleagues alike; however, the team responsible for publication of Pathology in Practice looks forward with some confidence to a better 2021.
In a new report from the Microbiology Society, experts from around the UK explain the desperate need for long-term and ambitious funding for surveillance and research into antimicrobial resistance (AMR).
The Biomedical Science Industry Handbook 2021 is now available as a hard copy and in digital format. It provides comprehensive information on the full range of products and services from the in vitro diagnostics (IVD) industry.
Hummingbird Bioscience, a clinical-stage biotechnology company focused on developing revolutionary therapies for hard-to-drug targets, has announced a collaboration with Tempus, a leader in artificial intelligence (AI) and precision medicine.
Boston Cell Standards will present the results of a Canadian study that tested the first system of reference materials for standardisation of oestrogen receptor (ER) testing for breast cancer at the virtual San Antonio Breast Cancer Symposium.
CliniSys Group has formed a partnership with Software Testing Solutions (STS) that will support CliniSys’ delivery of automated software testing services for its WinPath Enterprise LIMS and ICE solutions.
In the third article in his series on method comparisons, Stephen MacDonald focuses on what differences are expected and acceptable, and what other factors need further investigation. Read the full feature in the December issue.
Triaging patients presenting with acute respiratory infection symptoms in the influenza season can be a minefield, without the added pressure of a global pandemic. Distinguishing between viral and bacterial infections can inform treatment decisions.